160212-35-1

160212-35-1 structure

Name: Nelipepimut-S
Chemical Name: Nelipepimut-S
CAS Number: 160212-35-1
Molecular Formula: C₅₀H₇₈N₁₀O₁₁
Molecular Weight: 995.215
Catalog: Signaling Pathways JAK/STAT Signaling EGFR
Create Date: 2018-06-05 05:26:09
Modify Date: 2024-01-19 05:07:19
Nelipepimut-S is a peptide vaccine which targets HER2. Nelipepimut-S has immune activity against HER2 positive breast cancer[1].

Name	Nelipepimut-S
Synonyms	NeuVax L-Lysyl-L-isoleucyl-L-phenylalanylglycyl-L-seryl-L-leucyl-L-alanyl-L-phenylalanyl-L-leucine Nelipepimut-S E75 peptide 7M0A29CD8B human receptor tyrosine-protein kinase erbB-2 (proto-oncogene Neu, tyrosine kinase- type cell surface receptor HER2, CD340)-(347-355)-peptide L-Leucine, L-lysyl-L-isoleucyl-L-phenylalanylglycyl-L-seryl-L-leucyl-L-alanyl-L-phenylalanyl-

Description	Nelipepimut-S is a peptide vaccine which targets HER2. Nelipepimut-S has immune activity against HER2 positive breast cancer[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> JAK/STAT Signaling >> EGFR Signaling Pathways >> Protein Tyrosine Kinase/RTK >> EGFR
Target	HER2
References	[1]. Dillon PM, et al. Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data. Breast Cancer (Dove Med Press). 2020 Apr 3;12:69-75.